Evidence map›Paper›PMID 28642603›Full record

ReviewNature reviews. Cancer2017

Imaging of anticancer drug action in single cells.

Miles A Miller, Ralph Weissleder

Abstract readReview
In one paragraph

Review in Nature reviews. Cancer, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed.

  1. Optical and Photoacoustic Imaging.Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer · 2026
    Review
  2. Review
  3. Preparation andRSC advances · 2023
    Article
  4. Multidimensional Imaging of Breast Cancer.Cold Spring Harbor perspectives in medicine · 2023
    Review
  5. Review
  6. Article
  7. Review
  8. Review
  9. In Vivo Click Chemistry Enables Multiplexed Intravital Microscopy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2022
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Multiphoton intravital microscopy of rodents.Nature reviews. Methods primers · 2022
    Article
  16. Article
  17. Pharmacodynamic measures within tumors expose differential activity of PD(L)-1 antibody therapeutics.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  18. Review
  19. Review
  20. Label-Free Multimodal Multiphoton Intravital Imaging.Advances in experimental medicine and biology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Miles A MillerCenter for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.
Ralph WeisslederCenter for Systems Biology, Massachusetts General Hospital, Boston, Massachusetts 02114, USA.

Funding

TRANSLATIONAL PHARMACOLOGY COREP50GM107618 · NIGMS · HARVARD MEDICAL SCHOOL · PI JURIC, DEJAN · 2014 to 2018
$10.8M
Training Grant in Molecular Imaging Research (MGH/HMS)T32CA079443 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2000 to 2025
$10.1M
Novel Clickdyes for Biomedical SensingR01EB010011 · NIBIB · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2010 to 2017
$3.1M
Imaging tumor associated macrophage (TAM) functionR01CA206890 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI PITTET, MIKAEL, WEISSLEDER, MD, PHD, RALPH · 2017 to 2021
$1.9M
Single Cell Imaging of the HeartR01HL122208 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI WEISSLEDER, MD, PHD, RALPH · 2014 to 2017
$1.7M
Single Cell In Vivo Imaging Technology to Analyze Taxane Nano Formulations in Breast CancerK99CA207744 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI MILLER, MILES A · 2016 to 2017
$359k
NCI NIH HHS K99 CA207744NCI NIH HHS R01 CA206890NCI NIH HHS T32 CA079443NHLBI NIH HHS R01 HL122208NIBIB NIH HHS R01 EB010011NIGMS NIH HHS P50 GM107618
6 · The paper itself

Abstract

Imaging is widely used in anticancer drug development, typically for whole-body tracking of labelled drugs to different organs or to assess drug efficacy through volumetric measurements. However, increasing attention has been drawn to pharmacology at the single-cell level. Diverse cell types, including cancer-associated immune cells, physicochemical features of the tumour microenvironment and heterogeneous cell behaviour all affect drug delivery, response and resistance. This Review summarizes developments in the imaging of in vivo anticancer drug action, with a focus on microscopy approaches at the single-cell level and translational lessons for the clinic.

Indexed as

ImmunotherapyIntravital MicroscopyAdaptive ImmunityAnimalsAntigen PresentationAntineoplastic AgentsDrug DiscoveryDrug Resistance, NeoplasmHumansMicroscopy, ConfocalMicroscopy, Fluorescence, MultiphotonNeoplasmsAntineoplastic Agents

Identifiers

PMID28642603
PMCPMC7552440

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.